CATALOGO DEI PRODOTTI DELLA RICERCA

MAFFICINI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.101
NA - Nord America 6.559
AS - Asia 5.118
SA - Sud America 743
AF - Africa 164
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.371
RU - Federazione Russa 2.606
SG - Singapore 1.805
CN - Cina 1.617
GB - Regno Unito 1.547
IT - Italia 995
BR - Brasile 577
VN - Vietnam 461
HK - Hong Kong 432
DE - Germania 398
SE - Svezia 343
IE - Irlanda 303
FR - Francia 291
FI - Finlandia 230
BD - Bangladesh 211
KR - Corea 150
CA - Canada 110
IN - India 85
NL - Olanda 77
AR - Argentina 61
UA - Ucraina 56
TR - Turchia 52
ES - Italia 51
MX - Messico 51
JP - Giappone 49
AT - Austria 44
ID - Indonesia 44
BE - Belgio 42
IQ - Iraq 42
PL - Polonia 32
ZA - Sudafrica 30
EC - Ecuador 28
NG - Nigeria 28
UZ - Uzbekistan 24
CO - Colombia 20
TG - Togo 20
MA - Marocco 19
PK - Pakistan 18
VE - Venezuela 18
BJ - Benin 16
CL - Cile 16
IR - Iran 16
AU - Australia 13
SA - Arabia Saudita 13
JO - Giordania 11
PH - Filippine 11
KE - Kenya 10
LT - Lituania 10
NO - Norvegia 10
TN - Tunisia 10
CH - Svizzera 9
EG - Egitto 9
KG - Kirghizistan 9
PY - Paraguay 9
LV - Lettonia 8
IL - Israele 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
MY - Malesia 5
OM - Oman 5
CR - Costa Rica 4
GA - Gabon 4
JM - Giamaica 4
NI - Nicaragua 4
PT - Portogallo 4
RO - Romania 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
RS - Serbia 3
TH - Thailandia 3
TW - Taiwan 3
BB - Barbados 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
IS - Islanda 2
KW - Kuwait 2
LB - Libano 2
PS - Palestinian Territory 2
QA - Qatar 2
Totale 19.686
Salva come PNG Salva come JPEG
Città #
Southend 1.322
Singapore 942
Moscow 891
Ashburn 753
Dallas 693
Chandler 664
San Jose 650
Verona 436
Hong Kong 427
Woodbridge 316
Beijing 288
Dublin 283
Ann Arbor 259
Jacksonville 243
New York 219
The Dalles 207
Council Bluffs 182
Ho Chi Minh City 133
Munich 127
Los Angeles 126
Jinan 101
Hanoi 99
Shenyang 98
Lawrence 87
Princeton 87
Houston 85
Nanjing 76
Wilmington 75
Helsinki 68
São Paulo 66
Hebei 57
Santa Clara 57
Tianjin 54
Turku 53
Buffalo 50
London 50
Redondo Beach 50
Orem 46
Zhengzhou 46
Changsha 42
Columbus 42
Redmond 42
Brussels 41
Haikou 41
Montreal 38
Ningbo 38
Milan 37
Hangzhou 36
Nanchang 34
Sindelfingen 34
Taizhou 34
Tokyo 34
Guangzhou 33
Dong Ket 32
Seattle 32
Seoul 31
Vienna 31
Frankfurt am Main 30
Shanghai 30
Rome 29
Toronto 29
Abuja 27
Jiaxing 27
Lancaster 27
Brescia 26
Johannesburg 26
Amsterdam 25
Warsaw 25
Jakarta 24
Chennai 23
Da Nang 23
Haiphong 23
San Francisco 23
Brooklyn 22
Nuremberg 22
Madrid 21
Mexico City 21
Taiyuan 21
Lanzhou 20
Lomé 20
Stockholm 20
Tashkent 20
Manchester 19
Baghdad 18
Bologna 18
Dearborn 18
Kent 18
Lappeenranta 18
Belo Horizonte 17
Boardman 17
Chicago 17
Poplar 17
Rio de Janeiro 17
Cotonou 16
Denver 16
Norwalk 15
Paris 15
Redwood City 15
Atlanta 14
City of London 14
Totale 12.021
Salva come PNG Salva come JPEG
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 376
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 283
Characterization of new monoclonal antibodies specific for the extracellular domain of PTPRG, a candidate tumour suppressor gene 283
Whole-genome landscape of pancreatic neuroendocrine tumours 281
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 269
Genomic characterization of hepatoid tumors: context matters 261
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 254
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 252
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 249
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 248
Nuovi approcci proteomici per l'identificazione di potenziali marcatori di neoplasie pancreatiche 246
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 239
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 239
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 235
Expression of transmembrane protein tyrosine phosphatase gamma (Ptpgamma) in normal and neoplastic human tissues. 231
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 228
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 226
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 219
MONOCLONAL ANTIBODY FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA 218
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 216
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 215
Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues 213
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 209
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 206
Urokinase Plasminogen Activator Receptor Could Be a New UsefulMarker in Pancreatic Cancer and Appears to Be Related to Survival 203
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 202
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 201
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 199
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 198
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 196
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 195
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 194
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 193
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 193
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 192
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 192
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 191
Pancreatic cancer genomics 191
Reporting tumor molecular heterogeneity in histopathological diagnosis 190
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 188
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 185
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 185
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 185
Comparative Lesions Analysis Through a Targeted Sequencing Approach 185
Author Correction: The landscape of viral associations in human cancers 183
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 182
In situ analysis of methylarginine 182
Fhit down-regulation is an early event in pancreatic carcinogenesis 177
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 177
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 177
Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. 175
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes 174
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 174
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 173
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 171
Splice variants as novel targets in pancreatic ductal adenocarcinoma 170
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer 168
FrequentNRG1fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression 168
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 167
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium 164
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 162
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 161
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 160
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 158
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 157
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 156
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 153
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 150
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 149
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. 149
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 147
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 145
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 144
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 144
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin 144
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 143
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients 142
Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium 137
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 136
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 130
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 130
Comprehensive molecular characterization of mitochondrial genomes in human cancers 129
Receptor type tyrosine phosphatase gamma (PTP gamma) is a novel dendritic cell marker 129
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 126
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 126
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 121
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 119
Solitary subependymal giant cell astrocytoma lacking TSC1/2 mutations and TTF-1 expression: A potential diagnostic pitfall 119
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities 117
Recurrent oligodendroglioma with changed 1p/19q status 116
The landscape of viral associations in human cancers 115
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 114
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis 114
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 111
Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy 111
Cerebellar mass in a 31-year-old woman 111
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions 107
Totale 18.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.491
article - articoli 55.862
book - libri 0
conference - conferenze 7.004
curatela - curatele 0
other - altro 494
patent - brevetti 542
selected - selezionate 0
volume - volumi 589
Totale 128.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/20221.067 93 329 54 75 59 24 33 66 33 29 77 195
2022/20231.800 115 233 143 297 157 445 14 126 202 11 30 27
2023/20241.117 48 71 72 101 117 223 46 119 16 73 184 47
2024/20253.090 127 142 173 473 185 143 201 153 399 184 343 567
2025/20269.184 572 484 709 1.425 2.219 581 763 513 763 586 244 325
Totale 19.966